The August 2015 "Hot Stuff" focuses on hair loss in observance of National Hair Loss Awareness Month.
Joe Niamtu III, DMD, shares his insights and experience with Kythera Biopharmaceuticals’ new fat-dissolving injectable Kybella in this August 2015 feature.
When worn for 90 seconds, three times a week, the LaserBand will stimulate and revitalize thinning hair, the company states.
New research suggests that substances from algae and fish mucus may form the basis for a new kind of sunscreen.
Shai Shinhar, MD, and his wife, Rachel, share tidbits about running their medspa together in the August 2015 "10 Things."
See the latest trends that people are talking about in the August 2015 "Spotlight."
The FDA gave its nod to the ReShape Integrated Dual Balloon System. It is meant to be temporary and should be removed 6 months after it is inserted.
Plastic surgeon and wine connoisseur Richard A. Baxter, MD, offers up his take on rose wines, and shares his favorites, in this August 2015 "InDepth" column.
The NFI gene is a “major player” in the development of melanoma, Yale University researchers report.
Angel Pierini and his sister, Angela, show that family and business do indeed mix. Find out for yourself in this August 2015 "Behind the Scenes" column.
In the August 2015 "The Verdict," Richard M. Escoffery, Esq, offers six simple, cost-effective steps to limit your potential liability from employment law claims.
spa_2 copy_opt
In the August 2015 "The Edge," author David Evans, PhD, MBA, discusses how to market a medspa online.
Odomzo is a pill taken once a day. It works by inhibiting the Hedgehog pathway, which is active in basal cell cancers.
PuraPly Box and Product
Organogenesis launches new PuraPly™ products at the APMA 2015 Annual Scientific Meeting in Orlando, Fla.
US News and World Report announces its rankings of the best ear, nose & throat hospitals for 2015-2016.
Treatment with the janus kinase (JAK) inhibitor XELJANZ® (tofacitinib citrate) led to dramatic improvement in six patients with moderate to severe eczema who had previously failed conventional therapies.
Scioderm's Zorblisa was the first drug to ever receive the FDA's breakthrough designation, and is the first drug to ever enter Phase 3 development for the treatment of EB.
Three-quarters of specialists, including dermatologists and ear, nose and throat doctors, made more money in 2014, a new survey shows.
There was significant variation in rates of secondary lip surgery and secondary rhinoplasty at the four cleft palate centers, and more research is needed to better understand why this is occurring.
The US regained its No. 1 spot for most cosmetic surgical and nonsurgical procedures after being ousted by Brazil in 2013, ISAPS reports.